IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells

Journal of Experimental Medicine

Volumn 210, Issue 6, 2013, Pages 1065-1068

  Gasteiger, Georg ^a,b   Hemmers, Saskia ^a,b   Firth, Matthew A ^b   Floc'h, Audrey Le ^b   Huse, Morgan ^b   Sun, Joseph C ^b   Rudensky, Alexander Y ^a,b  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL ADHESION; CELL LINEAGE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; MOUSE; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; TARGET CELL; ANIMAL; C57BL MOUSE; CELL CULTURE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

ANIMALS; AUTOIMMUNITY; CELL ADHESION; CELLS, CULTURED; IMMUNE TOLERANCE; INTERLEUKIN-2; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES, REGULATORY;

EID: 84880669245     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20122462     Document Type: Article

References (42)

1. Barao, I., A.M. Hanash, W. Hallett, L.A. Welniak, K. Sun, D. Redelman, B.R. Blazar, R.B. Levy, and W.J. Murphy. 2006. Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells. Proc. Natl. Acad. Sci. USA. 103:5460-5465. http://dx.doi.org/10.1073/pnas.0509249103
2. Bihl, F., J. Pecheur, B. Bréart, G. Poupon, J. Cazareth, V. Julia, N. Glaichenhaus, and V.M. Braud. 2010. Primed antigen-specific CD4+ T cells are required for NK cell activation in vivo upon Leishmania major infection. J. Immunol. 185:2174-2181. http://dx.doi.org/10.4049/jimmunol.1001486
3. Caligiuri, M.A., C. Murray, M.J. Robertson, E. Wang, K. Cochran, C. Cameron, P. Schow, M.E. Ross, T.R. Klumpp, R.J. Soiffer, et al. 1993. Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. J. Clin. Invest. 91:123-132. http://dx.doi.org/10.1172/JCI116161
4. Challa-Malladi, M., Y.K. Lieu, O. Califano, A.B. Holmes, G. Bhagat, V.V. Murty, D. Dominguez-Sola, L. Pasqualucci, and R. Dalla-Favera. 2011. Combined genetic inactivation of β2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell. 20:728-740. http://dx.doi.org/10.1016/j.ccr.2011.11.006
5. Elliott, J.M., and W.M. Yokoyama. 2011. Unifying concepts of MHCdependent natural killer cell education. Trends Immunol. 32:364-372. http://dx.doi.org/10.1016/j.it.2011.06.001
6. Fehniger, T.A., S.F. Cai, X. Cao, A.J. Bredemeyer, R.M. Presti, A.R. French, and T.J. Ley. 2007. Acquisition of murine NK cell cytotoxicity requires the translation of a pre-existing pool of granzyme B and perforin mRNAs. Immunity. 26:798-811. http://dx.doi.org/10.1016/j.immuni.2007.04.010
7. Fernandez, N.C., E. Treiner, R.E. Vance, A.M. Jamieson, S. Lemieux, and D.H. Raulet. 2005. A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood. 105:4416-4423. http://dx.doi.org/10.1182/blood-2004-08-3156
8. Feuerer, M., Y. Shen, D.R. Littman, C. Benoist, and D. Mathis. 2009. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity. 31:654-664. http://dx.doi.org/10.1016/j.immuni.2009.08.023
9. French, A.R., H. Sjölin, S. Kim, R. Koka, L. Yang, D.A. Young, C. Cerboni, E. Tomasello, A. Ma, E. Vivier, et al. 2006. DAP12 signaling directly augments proproliferative cytokine stimulation of NK cells during viral infections. J. Immunol. 177:4981-4990.
10. Galani, I.E., M. Wendel, A. Stojanovic, M. Jesiak, M.M. Müller, C. Schellack, E. Suri-Payer, and A. Cerwenka. 2010. Regulatory T cells control macrophage accumulation and activation in lymphoma. Int. J. Cancer. 127: 1131-1140. http://dx.doi.org/10.1002/ijc.25132
11. Gasteiger, G., and W. Kastenmuller. 2012. Foxp3+ regulatory T-cells and IL-2: The Moirai of T-cell fates? Front Immunol. 3:179. http://dx.doi.org/10.3389/fimmu.2012.00179
12. Ghiringhelli, F., C. Ménard, M. Terme, C. Flament, J. Taieb, N. Chaput, P.E. Puig, S. Novault, B. Escudier, E. Vivier, et al. 2005. CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-β-dependent manner. J. Exp. Med. 202:1075-1085. http://dx.doi.org/10.1084/jem.20051511
13. Henney, C.S., K. Kuribayashi, D.E. Kern, and S. Gillis. 1981. Interleukin-2 augments natural killer cell activity. Nature. 291:335-338. http://dx.doi.org/10.1038/291335a0
14. Horng, T., J.S. Bezbradica, and R. Medzhitov. 2007. NKG2D signaling is coupled to the interleukin 15 receptor signaling pathway. Nat. Immunol. 8:1345-1352. http://dx.doi.org/10.1038/ni1524
15. Horowitz, A., K.C. Newman, J.H. Evans, D.S. Korbel, D.M. Davis, and E.M. Riley. 2010. Cross-talk between T cells and NK cells generates rapid effector responses to Plasmodium falciparum-infected erythrocytes. J. Immu-nol. 184:6043-6052. http://dx.doi.org/10.4049/jimmunol.1000106
16. Horowitz, A., J.C. Hafalla, E. King, J. Lusingu, D. Dekker, A. Leach, P. Moris, J. Cohen, J. Vekemans, T. Villafana, et al. 2012. Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS, S/AS01 malaria vaccine. J. Immunol. 188:5054-5062. http://dx.doi.org/10.4049/jimmunol.1102710
17. Jamieson, A.M., A. Diefenbach, C.W. McMahon, N. Xiong, J.R. Carlyle, and D.H. Raulet. 2002. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity. 17:19-29. http://dx.doi.org/10.1016/S1074-7613(02)00333-3
18. Joncker, N.T., and D.H. Raulet. 2008. Regulation of NK cell responsiveness to achieve self-tolerance and maximal responses to diseased target cells. Immunol. Rev. 224:85-97. http://dx.doi.org/10.1111/j.1600-065X.2008.00658.x
19. Josefowicz, S.Z., L.F. Lu, and A.Y. Rudensky. 2012. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30:531-564. http://dx.doi.org/10.1146/annurev.immunol.25.022106.141623
20. Kim, J.M., J.P. Rasmussen, and A.Y. Rudensky. 2007. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol. 8:191-197. http://dx.doi.org/10.1038/ni1428
21. Kündig, T.M., H. Schorle, M.F. Bachmann, H. Hengartner, R.M. Zinkernagel, and I. Horak. 1993. Immune responses in interleukin-2-deficient mice. Science. 262:1059-1061. http://dx.doi.org/10.1126/science.8235625
22. Laouar, Y., F.S. Sutterwala, L. Gorelik, and R.A. Flavell. 2005. Transforming growth factor-beta controls T helper type 1 cell development through regulation of natural killer cell interferon-gamma. Nat. Immunol. 6:600-607. http://dx.doi.org/10.1038/ni1197
23. Lee, S.H., M.F. Fragoso, and C.A. Biron. 2012. Cutting edge: a novel mechanism bridging innate and adaptive immunity: IL-12 induction of CD25 to form high-affinity IL-2 receptors on NK cells. J. Immunol. 189:2712-2716. http://dx.doi.org/10.4049/jimmunol.1201528
24. Li, M.O., S. Sanjabi, and R.A. Flavell. 2006. Transforming growth factorbeta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity. 25:455-471. http://dx.doi.org/10.1016/j.immuni.2006.07.011
25. Long, S.A., M. Rieck, S. Sanda, J.B. Bollyky, P.L. Samuels, R. Goland, A. Ahmann, A. Rabinovitch, S. Aggarwal, D. Phippard, et al; Diabetes TrialNet and the Immune Tolerance Network. 2012. Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function. Diabetes. 61:2340-2348. http://dx.doi.org/10.2337/db12-0049
26. Maldonado, R.A., D.J. Irvine, R. Schreiber, and L.H. Glimcher. 2004. A role for the immunological synapse in lineage commitment of CD4 lymphocytes. Nature. 431:527-532. http://dx.doi.org/10.1038/nature02916
27. Migone, T.S., N.A. Cacalano, N. Taylor, T. Yi, T.A. Waldmann, and J.A. Johnston. 1998. Recruitment of SH2-containing protein tyrosine phosphatase SHP-1 to the interleukin 2 receptor; loss of SHP-1 expression in human T-lymphotropic virus type I-transformed T cells. Proc. Natl. Acad. Sci. USA. 95:3845-3850. http://dx.doi.org/10.1073/pnas.95.7.3845
28. Ni, J., M. Miller, A. Stojanovic, N. Garbi, and A. Cerwenka. 2012. Sustained effector function of IL-12/15/18-preactivated NK cells against established tumors. J. Exp. Med. 209:2351-2365. http://dx.doi.org/10.1084/jem.20120944
29. O'Leary, J.G., M. Goodarzi, D.L. Drayton, and U.H. von Andrian. 2006. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 7:507-516. http://dx.doi.org/10.1038/ni1332
30. Oppenheim, D.E., S.J. Roberts, S.L. Clarke, R. Filler, J.M. Lewis, R.E. Tigelaar, M. Girardi, and A.C. Hayday. 2005. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat. Immunol. 6:928-937. http://dx.doi.org/10.1038/ni1239
31. Orange, J.S., S. Roy-Ghanta, E.M. Mace, S. Maru, G.D. Rak, K.B. Sanborn, A. Fasth, R. Saltzman, A. Paisley, L. Monaco-Shawver, et al. 2011. IL-2 induces a WAVE2-dependent pathway for actin reorganization that enables WASp-independent human NK cell function. J. Clin. Invest. 121:1535-1548. http://dx.doi.org/10.1172/JCI44862
32. Paust, S., H.S. Gill, B.Z. Wang, M.P. Flynn, E.A. Moseman, B. Senman, M. Szczepanik, A. Telenti, P.W. Askenase, R.W. Compans, and U.H. von Andrian. 2010. Critical role for the chemokine receptor CXCR6 in NK cell-mediated antigen-specific memory of haptens and viruses. Nat. Immunol. 11:1127-1135. http://dx.doi.org/10.1038/ni.1953
33. Sitrin, J., A. Ring, K.C. Garcia, C. Benoist, and D. Mathis. 2013. T reg cells control NK cells in an insulitic lesion by depriving them of IL-2. J. Exp. Med. 210:1153-1165.
34. Smyth, M.J., M.W. Teng, J. Swann, K. Kyparissoudis, D.I. Godfrey, and Y. Hayakawa. 2006. CD4+CD25+ T regulatory cells suppress NK cellmediated immunotherapy of cancer. J. Immunol. 176:1582-1587.
35. Su, H.C., J.S. Orange, L.D. Fast, A.T. Chan, S.J. Simpson, C. Terhorst, and C.A. Biron. 1994. IL-2-dependent NK cell responses discovered in virus-infected beta 2-microglobulin-deficient mice. J. Immunol. 153: 5674-5681.
36. Sun, J.C., and L.L. Lanier. 2008. Tolerance of NK cells encountering their viral ligand during development. J. Exp. Med. 205:1819-1828. http://dx.doi.org/10.1084/jem.20072448
37. Sun, J.C., and L.L. Lanier. 2011. NK cell development, homeostasis and function: parallels with CD8+ T cells. Nat. Rev. Immunol. 11:645-657. http://dx.doi.org/10.1038/nri3044
38. Sun, J.C., J.N. Beilke, and L.L. Lanier. 2009. Adaptive immune features of natural killer cells. Nature. 457:557-561. http://dx.doi.org/10.1038/nature07665
39. Terme, M., N. Chaput, B. Combadiere, A. Ma, T. Ohteki, and L. Zitvogel. 2008. Regulatory T cells control dendritic cell/NK cell cross-talk in lymph nodes at the steady state by inhibiting CD4+ self-reactive T cells. J. Immunol. 180:4679-4686.
40. Tripathy, S.K., P.A. Keyel, L. Yang, J.T. Pingel, T.P. Cheng, A. Schneeberger, and W.M. Yokoyama. 2008. Continuous engagement of a self-specific activation receptor induces NK cell tolerance. J. Exp. Med. 205:1829-1841. http://dx.doi.org/10.1084/jem.20072446
41. Vivier, E., D.H. Raulet, A. Moretta, M.A. Caligiuri, L. Zitvogel, L.L. Lanier, W.M. Yokoyama, and S. Ugolini. 2011. Innate or adaptive immunity? The example of natural killer cells. Science. 331:44-49. http://dx.doi.org/10.1126/science.1198687
42. Xiao, W., H. Hong, Y. Kawakami, Y. Kato, D. Wu, H. Yasudo, A. Kimura, H. Kubagawa, L.F. Bertoli, R.S. Davis, et al. 2009. Tumor suppression by phospholipase C-beta3 via SHP-1-mediated dephosphorylation of Stat5. Cancer Cell. 16:161-171. http://dx.doi.org/10.1016/j.ccr.2009.05.018